Expo 2030 to Boost Vital Sectors in Saudi Arabia

Saudi Arabia allocated a sum of 7.8 billion dollars to host the global fair (AFP)
Saudi Arabia allocated a sum of 7.8 billion dollars to host the global fair (AFP)
TT

Expo 2030 to Boost Vital Sectors in Saudi Arabia

Saudi Arabia allocated a sum of 7.8 billion dollars to host the global fair (AFP)
Saudi Arabia allocated a sum of 7.8 billion dollars to host the global fair (AFP)

Economic analysts anticipate that Riyadh’s successful bid to host the Expo 2030 world fair will catalyze a significant boost in Saudi Arabia’s economy, contributing approximately $50 billion.

This triumph is expected to attract foreign investments and foster prosperity and growth across various vital economic sectors in the Kingdom.

Among these sectors are aviation, transportation, real estate, housing, communications, logistics, retail, hotels, hospitality, and tourism.

The exhibition is poised to provide a substantial opportunity for both local and international companies to attract foreign investments.

Mohammed bin Dleim Al-Qahtani, an economics professor at King Faisal University, shared his insights with Asharq Al-Awsat, predicting that organizing the fair will enhance Saudi Arabia’s economic activities by around $50 billion.

This, in turn, will drive development in several crucial and vibrant economic sectors, affirmed Al-Qahtani.

The exhibition’s revenues, according to Al-Qahtani, will be distributed across various sectors: restaurants and hotels (approximately $5 billion), contracting ($11.5 billion), business services and event organization ($28 billion), and small project expenditures ($5.5 billion).

Furthermore, the world fair is expected to create approximately 60,000 jobs annually until the exhibition date, with a total estimated employment reaching 420,000 positions.

In Al-Qahtani’s opinion, the success of hosting Expo 2030 is set to enhance Saudi Arabia’s global image as a leader in hosting international events, fostering global communication, travel, and tourism.

This achievement is expected to bolster the Kingdom’s Gross Domestic Product (GDP) by more than 2.5%, propel key sectors outlined in “Vision 2030” forward, attract over 50 million visitors during the exhibition's duration, stimulate real estate growth, catalyze long-term investments, and significantly support the knowledge-based economy.

Meanwhile, Mohammed Mokni, a financial and investment expert and the CEO of “Ethmar,” a company owned by Imam Mohammed bin Saud University in Saudi Arabia, described Riyadh's win in hosting the exhibition as a testament to the Kingdom’s global stature.

Mokni emphasized the world's confidence in Saudi Arabia’s ability to organize this major global event, where it competes with leading nations in providing grand venues, superior services, infrastructure, and logistical aspects, as well as financial readiness.

The CEO highlighted that the Saudi bid considered all these facets, showcasing exceptional hosting capabilities from the first round of voting, leading to this exceptional victory.

Mokni further stated that this victory serves as international recognition of the Kingdom’s success in implementing its developmental plans and projects stemming from “Vision 2030,” initiated in 2015.

It also reflects the economic and political strength, resilience, and capability of Saudi Arabia, stressed Mokni.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.